What Happened?
Cambridge, MA-based Generation Bio Appointed Milton Pires as Associate Director, External Reporting and Treasury
Date of management change: April 01, 2022
Cambridge, MA-based Generation Bio Appointed Milton Pires as Associate Director, External Reporting and Treasury
Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company`s non-viral platform incorporates a novel DNA construct called closed-ended DNA, or ceDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, or RES, to produce ceDNA. The platform is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific tissues, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio`s manufacturing scale to hundreds of millions of doses to support their mission to extend the reach of genetic medicine to more people, living with more diseases, around the world.
Milton Pires is Associate Director, External Reporting and Treasury at Generation Bio. Previously, Milton held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Pradhan Yatin, Frese Anne, Mohan Shalabh, Brajcich Gerry, Perry Kelly, Kakascik Caisey, Loveday Susan, Oxford Jeff, Zuckerberg Kenneth, Anderson Jennifer, Uster Stacy
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.